Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension-Reference-Cited by-同舟云学术

Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension

Published:2003-05-23 Issue:6 Volume:17 Page:425-432
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Chrysant S G,Marbury T C,Robinson T D

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/1001577.pdf

Reference26 articles.

1. Birkenhager WH, de Leeuw PW . Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension. J Hypertens 1999; 17: 873–881.

2. Burnier M, Brunner HR . Comparative antihypertensive effects of angiotensin II receptor antagonists. J Am Soc Nephrol 1999; 10 (Suppl 12): S278–S282.

3. Neutel J . Safety and efficacy of angiotensin II receptor antagonists. Am J Cardiol 1999; 84: 13K–17K.

4. Neutel J . Clinical studies of CS-866, the newest angiotensin II receptor antagonist. Am J Cardiol 2001; 87 (Suppl): 37C–43C.

5. Stumpe KO, Ludwig M . Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs. J Hum Hypertens 2002; 16 (Suppl 2): S24–S28.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis;Annals of Medicine;2024-06-03

2. Personalized Antihypertensive Treatment Optimization With Smartphone‐Enabled Remote Precision Dosing of Amlodipine During the COVID‐19 Pandemic (PERSONAL‐CovidBP Trial);Journal of the American Heart Association;2024-02-20

3. Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta‐analysis;The Journal of Clinical Hypertension;2022-03-02

4. A New Clinical Utility For Tubular Markers To Identify Kidney Responders To Saxagliptin Treatment In Patients With Diabetic Nephropathy;Canadian Journal of Diabetes;2021-08

5. Saxagliptin and vildagliptin lowered albuminuria in patients with diabetes and hypertension independent on glycaemic control;International Journal of Clinical Practice;2020-11-09